
Enabling successful teams
- Alyson Joyce BD Operations @ Servier
- Jean Baptiste de Peretti Senior Manager @ Ipsen
- Arun S. Bisht Head of Excellence and Operations @ Novartis
Explore strategies helping build cultures of excellence and innovation within top biopharma companies, establishing new best practices enabling teams across an organization to deliver successful partnering, discovery, and development.
HIGHLIGHTS
- - Introduction from Gilles Toulemonde - CEO @ Inpart
- - Alyson Joyce, BD Operations @ Servier
- - Jean Baptiste de Peretti, Senior Manager, Global late-stage partnering @ Ipsen
- - Arun S. Bisht, Head of Excellence and Operations, Corporate and Business Development @ Novartis
- - Audience Q&A and discussion
- - Closing remarks
Key talking points
Alyson Joyce
Restructuring for Impact
Alyson shared a story of transformation at Servier, where, a few years ago, she led a restructuring effort to solve persistent issues in business development operations. Despite having processes, tools, and practices in place, she found cracks appearing in governance, communication, and data quality. Her commitment to addressing these pain points led to the creation of a new role: the “BD Coordination Officer,” designed to centralize project management from start to finish.
Empowering Teams Through New Roles
Alyson took a bold step by reorganizing roles within the team, pulling secondary tasks like data management and governance preparation away from licensing leads. By shifting these responsibilities to the BD Coordination Officers, who were trained to manage projects with consistency, the teams could focus on their core activities of search and evaluation. She emphasized that this change allowed the company to adapt rapidly to increased volume without sacrificing quality.
Navigating Resistance and Driving Change
Implementing this new structure wasn’t easy. Alyson faced initial pushback from teams who were accustomed to the old ways, but she persisted, presenting the benefits and gradually proving the value of the new model. Over time, the teams came to view the BD Coordination Officers as partners in the process rather than just administrative support. Her leadership in managing change led to significant improvements in data reliability and process consistency.
Upskilling and Autonomy
Alyson was also instrumental in upskilling the new Coordination Officers, guiding them to learn the language of science, understand therapeutic area priorities, and step confidently into meetings with seasoned scientists. This approach not only elevated the team’s capability but also allowed the organization to scale seamlessly with increasing demands.
Jean-Baptiste de Peretti
Transforming Business Development at Ipsen
Jean-Baptiste recounted his journey at Ipsen, where he played a pivotal role in revitalizing the company’s use of Inpart, initially an underutilized tool. Tasked with embedding Inpart into the core of business development operations, he focused on redesigning processes to align the tool with Ipsen’s evolving needs, emphasizing that user engagement and management support were key to this transformation.
Championing a Culture of Knowledge Sharing
Jean-Baptiste spoke about the importance of maintaining a detailed record of corporate knowledge. By championing Inpart’s implementation, Jean-Baptiste helped Ipsen transition from fragmented communication methods (like emails and PowerPoints) to a centralized system that could track every opportunity’s history. This shift not only streamlined collaboration but also empowered teams to make informed decisions based on past experiences.
Adapting the Tool for Ipsen’s Needs
Jean-Baptiste’s approach was hands-on, working closely with different departments to customize Inpart. He spearheaded the development of the “one-pager” module, which facilitated early-stage assessments by allowing subject matter experts to input their feedback directly into the platform. This customization turned Inpart into a day-to-day tool for managing opportunities, making it integral to Ipsen’s processes.
Arun Bisht
Leading Transformation Amid Change at Novartis
Arun shared his experiences leading operational excellence at Novartis during a time of significant reorganization. As teams were being consolidated and processes were being standardized, Arun was brought in to navigate these changes and drive alignment across various business development functions. His efforts focused on creating a unified process for evaluating opportunities, ensuring consistency across therapeutic areas.
Harnessing Inpart as a Central Repository
For Arun, Inpart wasn’t just a tool but a vital component of Novartis’ corporate memory. He described how the platform became the first point of reference when evaluating assets, serving as a repository for past interactions, decisions, and reasons for declining opportunities. His personal commitment to improving data rigor led to the establishment of checklists and protocols to ensure critical information was consistently captured.
Balancing Legacy Systems and New Approaches
Arun acknowledged the challenges of integrating new processes while dealing with legacy data stored across various formats. He worked closely with his team to maintain a “one source of truth” approach in Inpart, while recognizing that some information still needed to be managed outside the system. His narrative underscored the ongoing journey toward fully harmonizing data management practices.
Continue watching
Partnering 2030 & Top Pharma rankings
The session introduced the Partnering 2030 program, covering the key findings, and top pharma rankings for 2024.
- Sarah Issa Chief Marketing Officer @ Inpart
Sourcing the best science
This session featured presentations on best practices for sourcing early and late-stage science, the value of maintaining strong relationships, and tailored approaches to keeping diverse partners satisfied. It also reviewed the latest digital tools for optimal sourcing and building a global reputation for partnering.
- Patrick Speedie Chief Business Officer @ Inpart
- Nathan Lawless Director of External Innovation @ CSL
- Laurent Jacqueroud Business Development and Investment Director @ Cumulus Oncology
Recording not available.
Modernizing alliance management
This session covers alliance management strategies, balancing human relationships with technical operations.
- Shanker Shrestha Senior Solutions Consultant @ Inpart
- Daniel Goday Sagarra Associate Project Manager - Early Innovation @ Novo Nordisk
- Larissa Eheim Alliance Management Manager @ Genmab
- Julie Settipani Product Manager @ Inpart
Recording not available.
Leveraging advanced partnering data
This session covers alliance management strategies, balancing human relationships with technical operations.
- Echo Zhang VP of Product Strategy @ Inpart
- Rana Houry Product Manager @ Inpart
- Sofia Petta Consultant @ Evaluate Pharma